These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37755476)

  • 1. The largest lymph node defined response to neoadjuvant chemotherapy can predict long-term prognosis in locally advanced gastric cancer.
    Liu L; Wang Y; Liu T; Rao S; Zeng M
    Abdom Radiol (NY); 2023 Dec; 48(12):3653-3660. PubMed ID: 37755476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.
    Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
    Clin Transl Oncol; 2023 Aug; 25(8):2462-2471. PubMed ID: 37093455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P
    World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of a pathological response in metastatic lymph nodes of patients with gastric cancer who underwent neoadjuvant chemotherapy followed by surgery.
    Chen F; Xian J; Huo J
    Surg Today; 2024 Oct; 54(10):1255-1264. PubMed ID: 38587668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography.
    Güç ZG; Turgut B; Avci A; Cengiz F; Eren Kalender M; Alacacioğlu A
    Nucl Med Commun; 2022 May; 43(5):560-567. PubMed ID: 35045553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Learning Radiomics Nomogram Based on Enhanced CT to Predict the Response of Metastatic Lymph Nodes to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.
    Zhong H; Wang T; Hou M; Liu X; Tian Y; Cao S; Li Z; Han Z; Liu G; Sun Y; Meng C; Li Y; Jiang Y; Ji Q; Hao D; Liu Z; Zhou Y
    Ann Surg Oncol; 2024 Jan; 31(1):421-432. PubMed ID: 37925653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohort.
    Jiang Q; Liu W; Zeng X; Zhang C; Du Y; Zeng L; Yin Y; Fan J; Yang M; Tao K; Zhang P
    Front Immunol; 2023; 14():1122121. PubMed ID: 37215127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma.
    Makino T; Doki Y; Miyata H; Yasuda T; Yamasaki M; Fujiwara Y; Takiguchi S; Higuchi I; Hatazawa J; Monden M
    Surgery; 2008 Nov; 144(5):793-802. PubMed ID: 19081023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Response to Neoadjuvant Chemotherapy as an Independent Prognostic Factor in Metastatic Esophageal Cancer.
    Urakawa S; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
    Ann Surg; 2021 Jun; 273(6):1141-1149. PubMed ID: 31274656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative Surrogate Indicators of Gastric Cancer Patients' Long-Term Prognosis: The Number of Lymph Nodes Examined Relates to the Lymph Node Noncompliance Rate.
    Lin GT; Chen QY; Zhong Q; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Huang CM
    Ann Surg Oncol; 2020 Sep; 27(9):3281-3293. PubMed ID: 32212034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer.
    Wang X; Wei Y; Xue Y; Lu P; Yu L; Shen B
    PLoS One; 2016; 11(12):e0166836. PubMed ID: 27936109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy.
    Li Z; Li S; Ying X; Zhang L; Shan F; Jia Y; Ji J
    Gastric Cancer; 2020 May; 23(3):540-549. PubMed ID: 32072387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment.
    Liu Z; Wang Y; Shan F; Ying X; Zhang Y; Li S; Jia Y; Miao R; Xue K; Li Z; Li Z; Ji J
    BMC Gastroenterol; 2021 Jul; 21(1):283. PubMed ID: 34246249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
    Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
    Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.
    Liu YY; Fang WL; Wang F; Hsu JT; Tsai CY; Liu KH; Yeh CN; Chen TC; Wu RC; Chiu CT; Yeh TS
    Oncologist; 2017 Jan; 22(1):97-106. PubMed ID: 27789777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
    Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
    Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
    Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
    Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
    Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interval timing to surgery on tumor response after neoadjuvant treatment for gastric cancer.
    Ocaña Jiménez J; Priego P; Cuadrado M; Blázquez LA; Sánchez Picot S; Pastor Peinado P; Longo F; López F; Caminoa-Lizarralde MA; Galindo J
    Rev Esp Enferm Dig; 2020 Aug; 112(8):598-604. PubMed ID: 32496120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.